Tohru Yoneyama
Hirosaki, 0368562, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
CT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: January 06, 2026
Beyond Total PSA: Clinical Significance of S2,3PSA% in Reducing Unnecessary Prostate Biopsies.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: December 29, 2025
Integrated Assessment of Percentage α2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer.
Journal: European urology open science
Published: December 13, 2025
Immediate Postoperative cfDNA Elevation Predicts Pain After Robot-Assisted Radical Prostatectomy.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: August 25, 2025
Annexin A1-Targeted d-Peptide-Monomethyl Auristatin E Conjugate Enhanced Antitumor Effect of Monomethyl Auristatin E for Chemotherapy of Prostate Cancer.
Journal: The Prostate
Published: May 13, 2025
The Effects of the Blood-Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies.
Journal: The Prostate
Published: March 06, 2025
PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: October 14, 2024
Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study.
Journal: The world journal of men's health
Published: September 02, 2022
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab.
Journal: Scientific reports
Published: July 19, 2022
Last Updated: 09/26/2026